Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Norpace Cr
Generic Name
Disopyramide Phosphate
Active Ingredient
DisopyramideCategory
Other
Salt Form
Phosphate
Variants
2
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Norpace Cr, you must consult a qualified healthcare professional.
Detailed information about Norpace Cr
Disopyramide is a Class IA antiarrhythmic medication used primarily to treat life-threatening ventricular arrhythmias. It works by stabilizing the heart's electrical activity and possesses significant anticholinergic properties.
Dosage for disopyramide must be highly individualized based on patient response, tolerance, and underlying renal or hepatic function. The therapeutic range for plasma levels is generally considered to be 2 to 5 mcg/mL.
Disopyramide is not commonly used in pediatric populations, and its safety and efficacy have not been established in well-controlled clinical trials for children. However, when used off-label by specialists, dosing is strictly weight-based:
Because the kidneys are responsible for clearing over half of the drug, dose reductions are mandatory for patients with decreased kidney function.
In patients with liver cirrhosis or hepatic insufficiency, the half-life of disopyramide is prolonged. A reduced dose of 100 mg every 6 hours (or 200 mg every 12 hours for CR) is typically recommended to prevent toxicity.
Older adults are more susceptible to the anticholinergic effects of disopyramide (such as urinary retention and confusion) and often have age-related declines in renal function. Healthcare providers usually start at the lowest end of the dosing spectrum and monitor closely.
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose (within 2 hours for IR or 4 hours for CR), skip the missed dose and return to your regular schedule. Never double the dose to make up for a missed one, as this significantly increases the risk of heart rhythm complications.
Disopyramide overdose is a medical emergency and can be fatal. Signs of overdose include:
In the event of a suspected overdose, call emergency services immediately. Treatment typically involves gastric lavage, administration of activated charcoal, and intensive cardiac monitoring in a hospital setting.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without direct medical guidance, as sudden discontinuation can lead to a return of dangerous heart rhythms.
The most frequent side effects of disopyramide are related to its potent anticholinergic activity. These effects are dose-related and may include:
Disopyramide is a high-alert medication that requires careful clinical management. Patients must be aware that this drug can affect multiple organ systems beyond the heart. It is essential to maintain regular follow-up appointments for ECG monitoring and blood work. Because disopyramide can cause dizziness and blurred vision, patients should exercise caution when driving or operating heavy machinery until they know how the medication affects them.
There is no specific individual Black Box Warning for Disopyramide; however, it carries a class-wide warning based on the CAST trial results. This warning emphasizes that Class I antiarrhythmic drugs have not been shown to enhance survival in patients without life-threatening arrhythmias and may actually increase mortality in patients with structural heart disease or recent heart attacks. Therefore, Disopyramide should be used only for life-threatening ventricular arrhythmias.
Certain medications must never be used with disopyramide due to the risk of fatal heart rhythms or severe toxicity:
There are several conditions where the use of disopyramide is strictly prohibited because the risks clearly outweigh any potential benefits:
Disopyramide is classified as FDA Pregnancy Category C. Animal studies have shown some evidence of fetal harm, and there is limited data from well-controlled studies in humans. Disopyramide has been reported to induce uterine contractions in some pregnant women, potentially leading to premature labor. It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. If you are pregnant or planning to become pregnant, you must discuss the risks of untreated arrhythmia versus the risks of the medication with your cardiologist and obstetrician.
Disopyramide is excreted in human breast milk. Research indicates that the concentration in breast milk can be similar to that in the mother's plasma. Because of the potential for serious adverse reactions in nursing infants (such as heart rhythm changes or anticholinergic effects), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Safety and effectiveness in pediatric patients have not been established. While it is occasionally used off-label by pediatric electrophysiologists for specific arrhythmias, this requires extreme caution and weight-based dosing. Children may be more sensitive to the anticholinergic side effects, and long-term effects on growth and development have not been studied.
Disopyramide is a Class IA antiarrhythmic agent. Its primary molecular mechanism involves the blockade of the fast inward sodium current (INa) during the upstroke of the action potential (Phase 0). This blockade is 'state-dependent,' meaning the drug has a higher affinity for sodium channels that are in the open or inactivated state, which is common during rapid arrhythmias. By slowing the rate of rise of Phase 0, disopyramide decreases conduction velocity.
Additionally, disopyramide blocks outward potassium channels (IKr), which prolongs the duration of the action potential (Phase 3) and increases the effective refractory period. This prevents the heart from being re-excited too quickly. Its significant anticholinergic effect is due to competitive antagonism at muscarinic M2 receptors in the heart and M3 receptors in smooth muscle and glands.
The electrophysiological effects of disopyramide manifest on the ECG as a widening of the QRS complex and a prolongation of the QT interval. It has a potent negative inotropic effect, reducing the peak left ventricular dP/dt (a measure of heart contractility) by up to 20-50% depending on the dose. The onset of action for the immediate-release form is typically within 30 minutes to 3 hours.
Common questions about Norpace Cr
Disopyramide is primarily used to treat and prevent life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. It is a Class IA antiarrhythmic medication that helps stabilize the heart's electrical rhythm by blocking sodium and potassium channels. In some cases, it is also used off-label to treat symptoms of Hypertrophic Obstructive Cardiomyopathy (HOCM) because it can reduce the force of heart muscle contractions. Due to its potential for serious side effects, it is usually reserved for patients who do not respond to other treatments. Your healthcare provider will determine if this medication is appropriate based on the specific nature of your heart condition.
The most common side effects of disopyramide are related to its anticholinergic properties, which affect the 'rest and digest' system of the body. Many patients experience significant dry mouth, constipation, and blurred vision. Urinary hesitancy or difficulty starting urination is also very common, particularly in older men. Some patients may also feel dizzy, tired, or experience minor stomach upset. These side effects are often dose-related and should be discussed with your doctor, as they can sometimes be managed by adjusting the dosage or using supportive therapies.
It is generally recommended to avoid or strictly limit alcohol consumption while taking disopyramide. Alcohol can increase the risk of dizziness and lightheadedness already caused by the medication. Furthermore, alcohol can affect heart rhythms and blood sugar levels, which may complicate the management of your condition. In some patients, the combination of alcohol and disopyramide may lead to an increased risk of hypoglycemia (low blood sugar). Always consult your healthcare provider about the safety of alcohol use with your specific heart condition.
Disopyramide is classified as FDA Pregnancy Category C, meaning its safety during pregnancy has not been fully established. There is some evidence that the drug may cause uterine contractions, which could potentially lead to premature labor. It is generally only used during pregnancy if the benefit to the mother's life outweighs the potential risk to the fetus. If you are pregnant or planning to become pregnant, it is vital to have a detailed discussion with your cardiologist. They will weigh the risks of your heart arrhythmia against the potential risks of the medication to ensure the best outcome for both you and your baby.
For the immediate-release capsules, disopyramide is absorbed quickly, and therapeutic effects on the heart rhythm can often be seen within 30 minutes to 3 hours after the first dose. However, it may take several days of consistent dosing to reach a 'steady state' where the level of medicine in your blood remains constant. During this initial period, your doctor may monitor your heart rhythm closely, sometimes in a hospital setting. The controlled-release (CR) version takes longer to reach peak levels but provides a more sustained effect over 12 hours. The full benefit in conditions like HOCM may take longer to evaluate.
No, you should never stop taking disopyramide suddenly without your doctor's explicit instructions. Abruptly discontinuing an antiarrhythmic medication can cause a 'rebound' effect, where the dangerous heart rhythm the drug was treating returns suddenly and potentially more severely. If the medication needs to be stopped due to side effects or other reasons, your healthcare provider will provide a plan to taper the dose or transition you to another medication. In many cases, this transition is performed under continuous heart monitoring in a clinical setting to ensure your safety.
If you miss a dose of disopyramide, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. For immediate-release capsules, skip the dose if you are within 2 hours of the next one; for controlled-release, skip if within 4 hours. Never take two doses at once to make up for a missed one, as this can lead to toxic levels in the blood and dangerous heart rhythm changes. Setting an alarm can be a helpful way to ensure you take this medication at the required 6 or 12-hour intervals.
Disopyramide does not typically cause weight gain through increased body fat. However, sudden weight gain can be a sign of a very serious side effect: worsening heart failure. Because disopyramide can weaken the heart's ability to pump, the body may begin to retain fluid, leading to swelling in the ankles and a rapid increase in weight. If you notice a gain of more than 2-3 pounds in a single day or 5 pounds in a week, you should contact your healthcare provider immediately. This is a critical safety signal that requires medical evaluation.
Disopyramide has many significant drug interactions, so it must be used cautiously with other medications. It should not be combined with other drugs that prolong the QT interval, such as certain antibiotics or other antiarrhythmics, as this increases the risk of fatal heart rhythms. It also interacts with medications processed by the liver's CYP3A4 enzyme, including some antifungals and HIV medications. Even over-the-counter supplements like St. John's Wort can interfere with how disopyramide works. Always provide your doctor and pharmacist with a complete list of all medications and supplements you are currently taking.
Yes, disopyramide phosphate is available as a generic medication in both immediate-release and controlled-release formulations. The generic versions are required by the FDA to have the same active ingredient, strength, and effectiveness as the brand-name version (Norpace). Using the generic form can be a more cost-effective option for many patients. However, because this drug has a narrow therapeutic index, you should check with your doctor before switching between different manufacturers of the generic drug, as small variations in absorption can sometimes affect blood levels.
Other drugs with the same active ingredient (Disopyramide)
> Warning: Stop taking Disopyramide and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of disopyramide requires ongoing monitoring for cardiac function. Chronic anticholinergic effects can lead to long-term dental decay due to lack of saliva (dry mouth) and chronic constipation, which may require dietary adjustments or stool softeners. There is also a risk of developing tolerance to the antiarrhythmic effects, though this is less common than with some other agents.
While disopyramide does not currently carry a standard FDA 'Black Box' warning in the same way as some newer drugs, it is subject to the findings of the Cardiac Arrhythmia Suppression Trial (CAST). The CAST study demonstrated that certain Class I antiarrhythmic drugs (specifically encainide and flecainide) increased mortality in patients with a recent myocardial infarction (heart attack). While disopyramide was not part of the CAST trial, the FDA requires a general warning for Class I antiarrhythmics, stating they should be reserved for patients with life-threatening arrhythmias and are generally not recommended for patients with lesser arrhythmias or those without structural heart disease.
Report any unusual symptoms or changes in your health to your healthcare provider immediately to ensure your treatment remains safe and effective.
To ensure safety, healthcare providers will typically order the following tests:
Due to the high incidence of blurred vision and dizziness, patients are advised to avoid driving or operating dangerous equipment during the initiation of therapy or after any dose increase.
Alcohol should be avoided or strictly limited. Alcohol can increase the risk of dizziness and may also contribute to the development of arrhythmias or low blood sugar, complicating the clinical picture for patients on disopyramide.
Never stop taking disopyramide abruptly. Sudden discontinuation can lead to 'rebound' arrhythmias or a rapid return of the life-threatening rhythm for which the drug was prescribed. If the drug must be stopped, it is usually done under close medical supervision, often in a hospital setting.
> Important: Discuss all your medical conditions, especially any history of heart failure or kidney problems, with your healthcare provider before starting Disopyramide.
Disopyramide does not typically interfere with common laboratory tests, but it may affect the results of certain specialized tests for glucose metabolism due to its potential to cause hypoglycemia. Always inform laboratory staff that you are taking this medication.
For each major interaction, the mechanism usually involves either shared metabolic pathways (CYP3A4) or additive pharmacodynamic effects on the heart's electrical system. Management strategies often involve choosing alternative medications or performing more frequent ECG and blood level monitoring.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking to prevent dangerous interactions.
In these scenarios, a healthcare provider must perform a careful risk-benefit analysis:
There is no documented cross-sensitivity between disopyramide and other classes of antiarrhythmics (like lidocaine or amiodarone). However, patients who have had severe adverse reactions to other Class IA agents (like quinidine or procainamide) should be monitored with extra caution, as they may be more susceptible to the proarrhythmic effects of this class of drugs.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of heart block or glaucoma, before prescribing Disopyramide.
Clinical studies of disopyramide did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. However, elderly patients are known to have a higher risk of:
Healthcare providers typically start elderly patients on lower doses and monitor renal function closely.
For patients with a Glomerular Filtration Rate (GFR) or Creatinine Clearance (CrCl) below 40 mL/min, the dosing interval must be extended. Disopyramide is dialyzable, but the amount removed during hemodialysis varies. Patients on dialysis typically require supplemental doses or specific timing of their medication relative to their dialysis sessions.
In patients with liver disease, the metabolism of disopyramide is slowed, leading to a longer half-life. These patients require a reduction in the total daily dose (typically to 400 mg per day) to avoid accumulation and toxicity. Monitoring of liver function tests is recommended during long-term therapy.
> Important: Special populations, particularly the elderly and those with kidney disease, require individualized medical assessment and frequent monitoring to ensure Disopyramide therapy remains safe.
| Parameter | Value |
|---|---|
| Bioavailability | 70% - 90% |
| Protein Binding | 35% - 95% (Concentration-dependent) |
| Half-life | 4 - 10 hours (Normal renal function) |
| Tmax | 0.5 - 3 hours (IR); 4.9 hours (CR) |
| Metabolism | Hepatic (CYP3A4) |
| Excretion | Renal 50-60%, Fecal 10% |
Disopyramide belongs to the Class IA Antiarrhythmic class. Related medications include Quinidine and Procainamide. While all Class IA drugs share sodium and potassium channel blocking properties, disopyramide is distinguished by its much stronger anticholinergic and negative inotropic effects.